BIOLIFE SOLUTIONS, INC. (NASDAQ:BLFS) Files An 8-K Other Events

BIOLIFE SOLUTIONS, INC. (NASDAQ:BLFS) Files An 8-K Other Events
Item 8.01 Other Events.

Story continues below

On October 30, 2017,BioLife Solutions, Inc. (the“Company”) issued a press release announcing that the Company had received an aggregate of $1.9 million from the exercise of outstanding warrants. A copy of the press release is attached hereto as Exhibit 99.1 and incorporated by reference herein.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

99.1 Press Release dated October 30, 2017


BIOLIFE SOLUTIONS INC Exhibit
EX-99.1 2 tv477948_ex99-1.htm EXHIBIT 99.1   Exhibit 99.1          BioLife Solutions Receives $1.9 Million from Exercise of Warrants    BOTHELL,…
To view the full exhibit click here

About BIOLIFE SOLUTIONS, INC. (NASDAQ:BLFS)

BioLife Solutions, Inc. (BioLife) is engaged in the developing, manufacturing and marketing a portfolio of biopreservation tools and services for cells, tissues and organs, including clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud hosted biologistics cold chain management application for shippers. The Company’s product offerings include hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs; generic blood stem cell freezing and cell thawing media products; custom product formulation and custom packaging services; cold chain logistics services incorporating precision thermal packaging products and cloud-hosted Web applications, and contract aseptic manufacturing formulation, fill and finish services of liquid media products. Its products include HypoThermosol FRS, CryoStor, BloodStor, Cell Thawing Media, PrepaStor and biologistex cold-chain management service.

An ad to help with our costs